You have 9 free searches left this month | for more free features.

Parkinson's Disease; stem cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Regenerative Medicine Trial in Lahore (PRP and PBD-VSEL Stem Cell therapy)

Completed
  • Regenerative Medicine
  • PRP and PBD-VSEL Stem Cell therapy
  • Lahore, Punjab, Pakistan
    gull e Rukh
Nov 20, 2023

Parkinson's Disease Trial in Beijing (Autologous induced neural stem cell-derived DA precursor cells)

Recruiting
  • Parkinson's Disease
  • Autologous induced neural stem cell-derived DA precursor cells
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Jun 13, 2023

Parkinson Disease Trial in Madrid (StemRegen product)

Recruiting
  • Parkinson Disease
  • StemRegen product
  • Madrid, Spain
    Clinica Castello 68
Jan 22, 2023

Parkinson's Disease Who Previously Received BRT-DA01

Enrolling by invitation
  • Parkinson Disease
    • New York, New York
      Weill Cornell Medical College
    Jun 1, 2023

    Parkinson Disease Trial in Lund, Cambridge (STEM-PD)

    Recruiting
    • Parkinson Disease
    • STEM-PD
    • Lund, Sweden
    • +1 more
    Dec 7, 2022

    Parkinson's Disease Trial (Intracerebral microinjections)

    Withdrawn
    • Parkinson's Disease
    • Intracerebral microinjections
    • (no location specified)
    Apr 4, 2022

    Parkinson Disease Trial in Seoul (A9-DPC)

    Recruiting
    • Parkinson Disease
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    May 24, 2023

    Drug Discovery for Parkinson's With Mutations in the GBA Gene

    Recruiting
    • Parkinson Disease
    • +3 more
    • Biological Sample Collection
    • New York, New York
      The New York Stem Cell Foundation
    Sep 7, 2022

    Parkinson's Disease Trial in Houston (MSC+, MSC, Placebo)

    Active, not recruiting
    • Parkinson's Disease
    • MSC+placebo
    • +2 more
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Jan 26, 2022

    Parkinson Disease Trial in Sugar Land (HB-adMSCs, Placebo)

    Active, not recruiting
    • Parkinson Disease
    • HB-adMSCs
    • Placebo
    • Sugar Land, Texas
      Hope Biosciences Stem Cell Research Foundation
    Jul 20, 2022

    Parkinson Disease Trial in St. John's (AlloRx)

    Not yet recruiting
    • Parkinson Disease
    • AlloRx
    • St. John's, Antigua and Barbuda
      Medical Surgical Associates Center
    Jan 27, 2022

    Parkinson Disease Trial in Sugar Land (HB-adMSCs)

    Available
    • Parkinson Disease
    • HB-adMSCs
    • Sugar Land, Texas
      Hope Biosciences Stem Cell Research Foundation
    Jul 29, 2022

    Advanced Parkinson's Disease Trial in Orange, New York, Toronto (MSK-DA01, MSK-DA01 Cell Delivery Device)

    Active, not recruiting
    • Advanced Parkinson's Disease
    • MSK-DA01
    • MSK-DA01 Cell Delivery Device
    • Orange, California
    • +2 more
    May 31, 2022

    Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases Trial in Westport, Coral Springs, Dubai (Intravenous

    Recruiting
    • Neurologic Disorders
    • +25 more
    • Intravenous and Intranasal BMSC
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Parkinson's Disease Trial in Shanghai (hiPSC-DAP)

    Not yet recruiting
    • Parkinson's Disease
    • hiPSC-DAP
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Nov 22, 2023

    Parkinson Disease Trial in Amman (Injection of Umbilical cord derived MSCs)

    Active, not recruiting
    • Parkinson Disease
    • Injection of Umbilical cord derived MSCs
    • Amman, Jordan
      Cell Therapy Center, University of Jordan
    Aug 24, 2021

    Parkinson Disease Trial in San José (PASC transplantation (25 million PASCs/patient), Control)

    Active, not recruiting
    • Parkinson Disease
    • PASC transplantation (25 million PASCs/patient)
    • Control
    • San José, Costa Rica
    • +1 more
    Nov 28, 2023

    Transplantation:Mesenchymal Stem Cell Transplantation Trial in Minsk (Autologous mesenchymal stem cells, Placebo)

    Unknown status
    • Transplantation:Mesenchymal Stem Cell Transplantation
    • Autologous mesenchymal stem cells
    • Placebo
    • Minsk, Belarus
      the Belarusian Medical Academy of Postgraduate Education
    Feb 27, 2021

    Parkinson Disease Trial in Sugar Land (Biological/Vaccine: Allogeneic HB-adMSCs, Placebo)

    Recruiting
    • Parkinson Disease
    • Biological/Vaccine: Allogeneic HB-adMSCs
    • Placebo
    • Sugar Land, Texas
      Hope Biosciences Stem Cell Research Foundation
    Aug 2, 2021

    Parkinson Disease Trial (HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells))

    Available
    • Parkinson Disease
    • HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)
    • (no location specified)
    Sep 20, 2023

    Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)

    Not yet recruiting
    • Idiopathic Parkinson's Disease
    • hAESCs
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jan 28, 2023

    Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Trial in Bangkok (Progenitor Stem Cell Culture)

    Withdrawn
    • Alzheimer's Disease
    • +2 more
    • Progenitor Stem Cell Culture
    • Bangkok, Thailand
      Rajavithi Hospital
    Oct 14, 2020

    Parkinson's Disease Trial in Shanghai (hAESCs treatment, (saline))

    Not yet recruiting
    • Parkinson's Disease
    • hAESCs treatment
    • placebo (saline)
    • Shanghai, Shanghai, China
      Jingwen Wu
    Jun 23, 2022

    Parkinson's Disease Trial in Shijiazhuang (mesenchymal stem cells)

    Enrolling by invitation
    • Parkinson's Disease
    • mesenchymal stem cells
    • Shijiazhuang, Hebei, China
      Hebei Newtherapy BIo-Pharma Technology Co., Ltd
    Dec 29, 2021

    Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

    Not yet recruiting
    • Acute Leukemia
    • Rifaximin with allogeneic stem cell transplant
    • Allogeneic stem cell transplant
    • (no location specified)
    Sep 21, 2023